Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms

Context: Torin2 has various pharmacological properties. However, its anti-inflammatory activity has not been reported. Objective: This study focused on the potential anti-inflammatory properties of Torin2 in lipopolysaccharide (LPS)-evoked RAW264.7 murine macrophages. The study aimed to shed light o...

Full description

Bibliographic Details
Main Authors: Shanshan Wei, Ting Wang, Qi Cao, Xue Chen, Zhiyong Chu, Zhenzhen Zhang
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022012051
_version_ 1818017634442018816
author Shanshan Wei
Ting Wang
Qi Cao
Xue Chen
Zhiyong Chu
Zhenzhen Zhang
author_facet Shanshan Wei
Ting Wang
Qi Cao
Xue Chen
Zhiyong Chu
Zhenzhen Zhang
author_sort Shanshan Wei
collection DOAJ
description Context: Torin2 has various pharmacological properties. However, its anti-inflammatory activity has not been reported. Objective: This study focused on the potential anti-inflammatory properties of Torin2 in lipopolysaccharide (LPS)-evoked RAW264.7 murine macrophages. The study aimed to shed light on the molecular mechanisms that ameliorate these effects. Methods: Torin2 was applied to 100 ng/mL lipopolysaccharide-induced RAW 264.7 macrophages in vitro. Nitric oxide (NO) levels were detected using the Griess reagent kit. Prostaglandin E2 (PGE2), pro-inflammatory cytokines interleukin (IL)-1β, interleukin (IL)-6, and tumor necrosis factor in the supernatant fraction were determined using enzyme-linked immunosorbent assay (ELISA). Gene expression of pro-inflammatory cytokines, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) were tested using real-time quantitative polymerase chain reaction (qPCR). Cyclooxygenase-2 and inducible nitric oxide synthase proteins, phosphorylation of mitogen-activated protein kinase (MAPK) subgroups, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38, I-kappa-B-alpha (IκBα), and nuclear factor-kappa-B (NF-κB), and activation in extracts were detected via western blotting. Nuclear factor-kappa-B/p65 nuclear translocation was tested using an immunofluorescence assay. Results: The results demonstrated that pre-treatment with Torin2 profoundly attenuated the lipopolysaccharide-stimulated levels of nitric oxide and prostaglandin E2, pro-inflammatory cytokines, messenger ribonucleic acid (mRNA), and protein expression of cyclooxygenase-2 and inducible nitric oxide synthase. Collectively, Torin2 pre-treatment notably weakened lipopolysaccharide-induced damage by reducing the phosphorylation of nuclear factor-kappa-B, p38, c-Jun N-terminal kinase, extracellular signal-regulated kinase proteins, and nuclear factor-kappa-B/p65 nuclear translocation. Conclusion: Numerous pieces of evidence indicated that Torin2 reversed inflammatory activation by regulating nuclear factor-kappa-B and mitogen-activated protein kinase signaling pathways and provided a tentative potential candidate for preventing and treating inflammatory diseases.
first_indexed 2024-04-14T07:29:28Z
format Article
id doaj.art-bbc8bd55d7e947d5a300cda38ea2cf03
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-14T07:29:28Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-bbc8bd55d7e947d5a300cda38ea2cf032022-12-22T02:05:54ZengElsevierHeliyon2405-84402022-07-0187e09917Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanismsShanshan Wei0Ting Wang1Qi Cao2Xue Chen3Zhiyong Chu4Zhenzhen Zhang5Naval Medical Research Institute, Naval Medical University, Shanghai, 200433, ChinaNaval Medical Research Institute, Naval Medical University, Shanghai, 200433, ChinaSchool of Pharmacy, Naval Medical University, Shanghai, 200433, ChinaSchool of Pharmacy, Naval Medical University, Shanghai, 200433, ChinaNaval Medical Research Institute, Naval Medical University, Shanghai, 200433, China; Corresponding author.Naval Medical Research Institute, Naval Medical University, Shanghai, 200433, China; Corresponding author.Context: Torin2 has various pharmacological properties. However, its anti-inflammatory activity has not been reported. Objective: This study focused on the potential anti-inflammatory properties of Torin2 in lipopolysaccharide (LPS)-evoked RAW264.7 murine macrophages. The study aimed to shed light on the molecular mechanisms that ameliorate these effects. Methods: Torin2 was applied to 100 ng/mL lipopolysaccharide-induced RAW 264.7 macrophages in vitro. Nitric oxide (NO) levels were detected using the Griess reagent kit. Prostaglandin E2 (PGE2), pro-inflammatory cytokines interleukin (IL)-1β, interleukin (IL)-6, and tumor necrosis factor in the supernatant fraction were determined using enzyme-linked immunosorbent assay (ELISA). Gene expression of pro-inflammatory cytokines, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) were tested using real-time quantitative polymerase chain reaction (qPCR). Cyclooxygenase-2 and inducible nitric oxide synthase proteins, phosphorylation of mitogen-activated protein kinase (MAPK) subgroups, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38, I-kappa-B-alpha (IκBα), and nuclear factor-kappa-B (NF-κB), and activation in extracts were detected via western blotting. Nuclear factor-kappa-B/p65 nuclear translocation was tested using an immunofluorescence assay. Results: The results demonstrated that pre-treatment with Torin2 profoundly attenuated the lipopolysaccharide-stimulated levels of nitric oxide and prostaglandin E2, pro-inflammatory cytokines, messenger ribonucleic acid (mRNA), and protein expression of cyclooxygenase-2 and inducible nitric oxide synthase. Collectively, Torin2 pre-treatment notably weakened lipopolysaccharide-induced damage by reducing the phosphorylation of nuclear factor-kappa-B, p38, c-Jun N-terminal kinase, extracellular signal-regulated kinase proteins, and nuclear factor-kappa-B/p65 nuclear translocation. Conclusion: Numerous pieces of evidence indicated that Torin2 reversed inflammatory activation by regulating nuclear factor-kappa-B and mitogen-activated protein kinase signaling pathways and provided a tentative potential candidate for preventing and treating inflammatory diseases.http://www.sciencedirect.com/science/article/pii/S2405844022012051Torin2RAW264.7 murine macrophagesLipopolysaccharideAnti-inflammationMechanisms
spellingShingle Shanshan Wei
Ting Wang
Qi Cao
Xue Chen
Zhiyong Chu
Zhenzhen Zhang
Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms
Heliyon
Torin2
RAW264.7 murine macrophages
Lipopolysaccharide
Anti-inflammation
Mechanisms
title Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms
title_full Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms
title_fullStr Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms
title_full_unstemmed Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms
title_short Anti-inflammatory effects of Torin2 on lipopolysaccharide-treated RAW264.7 murine macrophages and potential mechanisms
title_sort anti inflammatory effects of torin2 on lipopolysaccharide treated raw264 7 murine macrophages and potential mechanisms
topic Torin2
RAW264.7 murine macrophages
Lipopolysaccharide
Anti-inflammation
Mechanisms
url http://www.sciencedirect.com/science/article/pii/S2405844022012051
work_keys_str_mv AT shanshanwei antiinflammatoryeffectsoftorin2onlipopolysaccharidetreatedraw2647murinemacrophagesandpotentialmechanisms
AT tingwang antiinflammatoryeffectsoftorin2onlipopolysaccharidetreatedraw2647murinemacrophagesandpotentialmechanisms
AT qicao antiinflammatoryeffectsoftorin2onlipopolysaccharidetreatedraw2647murinemacrophagesandpotentialmechanisms
AT xuechen antiinflammatoryeffectsoftorin2onlipopolysaccharidetreatedraw2647murinemacrophagesandpotentialmechanisms
AT zhiyongchu antiinflammatoryeffectsoftorin2onlipopolysaccharidetreatedraw2647murinemacrophagesandpotentialmechanisms
AT zhenzhenzhang antiinflammatoryeffectsoftorin2onlipopolysaccharidetreatedraw2647murinemacrophagesandpotentialmechanisms